Wednesday 19th August 2026
Investing Matters Logo
Mobile Icon
Investing Matters inline logo Close Menu
  • Home
  • Markets
  • Politics
  • UK
    • UK Investor
Search Icon
Investing Matters inline logo
Investing Matters inline logo Close Menu
  • Home
  • Markets
  • Politics
  • UK
    • UK Investor
Search Icon

Share Lookup

Search for shares listed on the London Stock Exchange

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

JX00.L

MORG.ST.B.V 27

View Share

JX07.L

MORG.ST.B.V 26

View Share

JX12.L

CITI FUN 26

View Share

JX14.L

HSBC BK. 31

View Share

JX16.L

CITI FUN 28

View Share

JX17.L

CITI FUN 26

View Share

JX21.L

CITI FUN 27

View Share

JX27.L

MOR.ST.EUR 27

View Share

JX31.L

CITI FUN 26

View Share

JX33.L

CITI FUN 26

View Share

JX36.L

CITI FUN 26

View Share

JX43.L

CITI FUN 26

View Share

JX44.L

CITI FUN 26

View Share

JX47.L

BARCLAYS 29

View Share

JX49.L

CITI FUN 26

View Share

JX71.L

CITI FUN 26

View Share

JX80.L

CITI FUN 31

View Share

JX96.L

MORG.ST.B.V 28

View Share

JXG.US

JX LUXVENTURE G

View Share

JXI.US

ISHARES GLOBAL

View Share

JXJT.US

JX LUXVENTURE L

View Share

JXN.A.US

JACKSON FINANCI

View Share

JXN.US

JACKSON FINANCI

View Share

JXSU.L

JPM GXUS REI UA

View Share

JXUD.L

JPM GXUS REI UD

View Share

JXUE.MI

JPM GLOBAL EX US RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS

View Share

JXUS.L

JPM GXUS REI UA

View Share

JXUS.MI

JPM GLOBAL EX US RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS

View Share

JXX.US

JANUS HENDERSON

View Share

JY02.L

CITI FUN 26

View Share
1379 items Page 44 of 46
  • First
  • Prev
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • Next
  • Last
Investing Matters Footer Logo

© Copyright 2026 Investing Matters
Website by: Revive.Digital

Sitemap

  • Home
  • Markets
  • Share Lookup

Most Read

IN BRIEF: Landore Resources shares remain suspended pending MRE

IN BRIEF: Landore Resources shares remain suspended pending MRE

19th Aug, 2026
MaxCyte buys gene therapy analytics firm SeQure Dx

MaxCyte buys gene therapy analytics firm SeQure Dx

19th Aug, 2026